Find Clinical Trial

Home » Find Clinical Trials » Perindopril Amlodipine Regimen versus AT1-Receptor Blocker/thiazide: a comparison of Blood pressure Lowering: Efficacy and Safety. A randomised, double blind, 9 month study of the efficacy and safety of four uptitrated doses of oral fixed combinations of perindopril/amlodipine, including a comparison with uptitrated doses of oral fixed combination of irbesartan and hydrochlorthiazide in mild to moderate hypertension.

Perindopril Amlodipine Regimen versus AT1-Receptor Blocker/thiazide: a comparison of Blood pressure Lowering: Efficacy and Safety. A randomised, double blind, 9 month study of the efficacy and safety of four uptitrated doses of oral fixed combinations of perindopril/amlodipine, including a comparison with uptitrated doses of oral fixed combination of irbesartan and hydrochlorthiazide in mild to moderate hypertension.

← Back

Study Phase	Phase 3

Therapeutic Area	Cardiovascular Diseases

Indication	Hypertension

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	AMLODIPINE, PERINDOPRIL ARGININE, S005985

Active Substance Code	S005985

Protocol Code	CL3-05985-006

EudraCT Code	2006-005799-42

ISRCTN Code	ISRCTN61335805

Documents and links

Results summary	READ MORE

Scientific publication	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.